Proteostasis Therapeutics
Why Robinhood?
You can watch PTI and buy or sell other stocks, ETFs, and their options commission-free!About PTI
Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb.
PTI Key Statistics
Stock Snapshot
The current Proteostasis Therapeutics(PTI) stock price is $1.89, with a market capitalization of 25.59M. The stock trades at a price-to-earnings (P/E) ratio of -0.50.
Proteostasis Therapeutics(PTI) stock opened on 2026-04-04 at —. The price climbed to — and dipped to —.
The Proteostasis Therapeutics(PTI)'s current trading volume is 0, compared to an average daily volume of 15.46K.
In the last year, Proteostasis Therapeutics(PTI) shares hit a 52-week high of $1.15 and a 52-week low of $0.18.
In the last year, Proteostasis Therapeutics(PTI) shares hit a 52-week high of $1.15 and a 52-week low of $0.18.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.